Scilex Holding Co - Sep 23, 2025 Form 4 Insider Report for Semnur Pharmaceuticals, Inc. (SMNR)

Role
10%+ Owner
Signature
/s/ Henry Ji, Scilex Holding Company, Chief Executive Officer and President
Stock symbol
SMNR
Transactions as of
Sep 23, 2025
Transactions value $
-$200,000,000
Form type
4
Date filed
9/25/2025, 07:49 PM
Previous filing
Sep 23, 2025
Next filing
Nov 28, 2025
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Scilex Holding Co 10%+ Owner 960 SAN ANTONIO RD, PALO ALTO /s/ Henry Ji, Scilex Holding Company, Chief Executive Officer and President 2025-09-25 0001820190
Scilex, Inc. 10%+ Owner 960 SAN ANTONIO RD, PALO ALTO /s/ Henry Ji, Scilex, Inc., Chief Executive Officer and President 2025-09-25 0002084647

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMNR Common Stock Sale -$191M -11.9M -6.17% $16.00 182M Sep 23, 2025 By Scilex, Inc. F1, F2
transaction SMNR Common Stock Sale -$8.88M -555K -52.6% $16.00 500K Sep 23, 2025 Direct F1, F2
holding SMNR Common Stock 6.25M Sep 23, 2025 By Scilex Bio, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to that certain Securities Purchase Agreement, dated September 23, 2025, by and among the Reporting Persons, the Issuer, and Biconomy PTE.LTD, as buyer.
F2 The purchase price was paid in Bitcoin blockchain based on the spot exchange rate for Bitcoin as published by Coinbase.com at 8:00 p.m. (New York City time) on the trading day immediately prior to the closing date of the purchase.